The document discusses renal disease in pregnancy, describing acute kidney injury (AKI) and chronic kidney disease (CKD) that can occur. It covers the causes, classification, clinical presentation, and treatment approaches for AKI during pregnancy, which can be difficult to diagnose due to normal physiologic changes. Management involves treating the underlying condition, supportive care including fluid management, and potentially dialysis in severe cases.
Renal disorders in pregnancy can range from asymptomatic bacteriuria to end-stage renal disease requiring dialysis, all being influenced by the physiologic changes of pregnancy. Women who have mild to moderate renal disease or a renal transplant are now challenging obstetricians and nephrologists with pregnancy.
The document provides an overview of renal physiology and function, including:
- The components and basic functions of the nephron, including filtration, reabsorption, and secretion in different parts of the nephron.
- Hormonal regulation of kidney function including renin, aldosterone, antidiuretic hormone, and erythropoietin.
- Changes in kidney anatomy and function that occur during pregnancy, including increased blood flow, glomerular filtration rate, and effects of progesterone on vasodilation and sodium retention.
- Considerations for managing pregnancy in women with chronic kidney disease, including risks of deterioration and importance of multidisciplinary management and monitoring.
The document discusses physiological changes during pregnancy that affect the kidneys. There is an increase in glomerular filtration rate and renal plasma flow by 50-60% due to rising plasma volume. Intraglomerular blood pressure remains unchanged despite these changes. Common renal complications in pregnancy include urinary tract infections, preeclampsia, acute renal failure, and renal calculi. Pregnancy poses risks but can be managed for women with pre-existing kidney disease through monitoring and adjusting treatment as needed.
Renal disease in pregnancy can cause complications for both the mother and fetus. Physiological changes in pregnancy include dilatation of the ureters and renal calyces as well as increased renal plasma flow and glomerular filtration rate, leading to higher levels of urinary protein and creatinine excretion. Urinary tract infections are more common in pregnancy and can cause maternal and neonatal morbidity if not properly treated. Chronic renal disease in pregnancy carries risks of preeclampsia, intrauterine growth restriction, and premature delivery that depend on the severity of renal impairment and presence of hypertension or proteinuria. Close monitoring and multidisciplinary management are important to optimize outcomes.
This document summarizes renal disorders that can occur in pregnancy. It discusses the normal physiologic changes in pregnancy that affect the kidneys as well as specific disorders like preeclampsia, hypertension, AKI, lupus nephritis, diabetic nephropathy, and nephrotic syndrome. It provides diagnostic criteria and recommendations for management and treatment for many of these conditions to help support healthy pregnancies and outcomes.
Dr Abdullah Ansari
MBBS, MD Medicine
Aligarh Muslim University
Physiological changes during pregnancy
Systemic changes
Renal changes
Renal function
Tubular function
Plasma osmolality
Anatomical changes
AKI during pregnancy
Pre-renal causes
Renal causes
Post-renal causes
Investigations
Management
This document provides an overview of acute kidney injury (AKI) in pregnancy. It discusses the definition of AKI in pregnancy, epidemiology, physiologic changes during pregnancy that impact the kidneys, common etiologies of AKI including preeclampsia, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. It also covers the diagnostic approach, differential diagnosis, and treatment considerations for AKI in pregnancy.
This document discusses various topics related to renal physiology and disease in pregnancy. It begins with an overview of the normal adaptations the kidneys undergo during pregnancy, including increases in kidney size, glomerular filtration rate (GFR), and decreased creatinine and blood urea nitrogen levels. It then covers specific topics like urinary tract infections (UTIs), hypertensive disorders of pregnancy, acute kidney injury, and chronic kidney disease in the context of pregnancy. For each topic, it provides details on pathogenesis, screening, treatment approaches, and management considerations for caring for pregnant patients with renal conditions.
Renal disorders in pregnancy can range from asymptomatic bacteriuria to end-stage renal disease requiring dialysis, all being influenced by the physiologic changes of pregnancy. Women who have mild to moderate renal disease or a renal transplant are now challenging obstetricians and nephrologists with pregnancy.
The document provides an overview of renal physiology and function, including:
- The components and basic functions of the nephron, including filtration, reabsorption, and secretion in different parts of the nephron.
- Hormonal regulation of kidney function including renin, aldosterone, antidiuretic hormone, and erythropoietin.
- Changes in kidney anatomy and function that occur during pregnancy, including increased blood flow, glomerular filtration rate, and effects of progesterone on vasodilation and sodium retention.
- Considerations for managing pregnancy in women with chronic kidney disease, including risks of deterioration and importance of multidisciplinary management and monitoring.
The document discusses physiological changes during pregnancy that affect the kidneys. There is an increase in glomerular filtration rate and renal plasma flow by 50-60% due to rising plasma volume. Intraglomerular blood pressure remains unchanged despite these changes. Common renal complications in pregnancy include urinary tract infections, preeclampsia, acute renal failure, and renal calculi. Pregnancy poses risks but can be managed for women with pre-existing kidney disease through monitoring and adjusting treatment as needed.
Renal disease in pregnancy can cause complications for both the mother and fetus. Physiological changes in pregnancy include dilatation of the ureters and renal calyces as well as increased renal plasma flow and glomerular filtration rate, leading to higher levels of urinary protein and creatinine excretion. Urinary tract infections are more common in pregnancy and can cause maternal and neonatal morbidity if not properly treated. Chronic renal disease in pregnancy carries risks of preeclampsia, intrauterine growth restriction, and premature delivery that depend on the severity of renal impairment and presence of hypertension or proteinuria. Close monitoring and multidisciplinary management are important to optimize outcomes.
This document summarizes renal disorders that can occur in pregnancy. It discusses the normal physiologic changes in pregnancy that affect the kidneys as well as specific disorders like preeclampsia, hypertension, AKI, lupus nephritis, diabetic nephropathy, and nephrotic syndrome. It provides diagnostic criteria and recommendations for management and treatment for many of these conditions to help support healthy pregnancies and outcomes.
Dr Abdullah Ansari
MBBS, MD Medicine
Aligarh Muslim University
Physiological changes during pregnancy
Systemic changes
Renal changes
Renal function
Tubular function
Plasma osmolality
Anatomical changes
AKI during pregnancy
Pre-renal causes
Renal causes
Post-renal causes
Investigations
Management
This document provides an overview of acute kidney injury (AKI) in pregnancy. It discusses the definition of AKI in pregnancy, epidemiology, physiologic changes during pregnancy that impact the kidneys, common etiologies of AKI including preeclampsia, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. It also covers the diagnostic approach, differential diagnosis, and treatment considerations for AKI in pregnancy.
This document discusses various topics related to renal physiology and disease in pregnancy. It begins with an overview of the normal adaptations the kidneys undergo during pregnancy, including increases in kidney size, glomerular filtration rate (GFR), and decreased creatinine and blood urea nitrogen levels. It then covers specific topics like urinary tract infections (UTIs), hypertensive disorders of pregnancy, acute kidney injury, and chronic kidney disease in the context of pregnancy. For each topic, it provides details on pathogenesis, screening, treatment approaches, and management considerations for caring for pregnant patients with renal conditions.
Renal changes during pregnancy include:
1. Structural changes such as increased kidney size and volume due to vascular and interstitial fluid changes.
2. Systemic changes including resetting of osmoregulation and volume regulation set points to accommodate increased plasma volume. Hormonal changes like increased progesterone, relaxin, and erythropoietin also impact renal function.
3. Renal hemodynamic changes with glomerular filtration rate increasing up to 50% in the first trimester due to reduced oncotic pressure and increased ultrafiltration capacity, remaining elevated through pregnancy.
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
The document discusses the effects of pregnancy on thyroid physiology and function. It notes that thyroid stimulating hormone (TSH) levels are initially suppressed in the first trimester due to increased human chorionic gonadotropin (hCG) but become a reliable indicator again later in pregnancy. It provides references ranges for TSH, free T4, and total T4 in pregnancy and discusses screening and treatment of hypothyroidism. Maternal hypothyroidism can impact both maternal and fetal health outcomes.
This document discusses hypertensive disorders in pregnancy. It defines various types of hypertensive disorders including pregnancy-induced hypertension, pre-eclampsia, eclampsia, and chronic hypertension. It provides details on the pathophysiology, risk factors, clinical features, investigations, management, and complications of pre-eclampsia and eclampsia. Common antihypertensive drugs used for treatment are also mentioned.
Hormonal changes during pregnancy allow for increased blood flow to the kidneys and altered autoregulation such that glomerular filtration rate (GFR) increases significantly through reductions in net glomerular oncotic pressure and increased renal size.
1. Renal disorders are common in pregnancy and can include urinary tract infections, nephrolithiasis, and acute or chronic renal failure.
2. Physiologic changes in pregnancy include increased renal plasma flow and glomerular filtration rate to accommodate the needs of the growing fetus.
3. Urinary tract infections are frequent in pregnancy and can lead to asymptomatic bacteriuria or acute pyelonephritis if not treated.
4. Acute renal failure in pregnancy is usually prerenal from causes like hemorrhage, preeclampsia, or sepsis. It requires fluid resuscitation and treatment of the underlying condition.
Here are a few key things we can do:
1. Provide thorough preconception counseling to assess risk and optimize medical condition before pregnancy if possible.
2. Ensure careful multidisciplinary antenatal care involving cardiologists, obstetricians, anesthesiologists to monitor for complications.
3. Plan delivery carefully considering hemodynamic changes, with options for early delivery or C-section if needed.
4. Be vigilant for dangerous periods like labor/delivery when changes in volume and pressure occur abruptly. Have low threshold for ICU admission.
5. Educate patients and families on warning signs and ensure close postpartum follow up as this is a high risk period.
6.
Renal disorders are common in pregnancy and can affect both mother and baby if not properly managed. The document discusses several types of renal disorders that may occur, including urinary tract infections, chronic kidney disease, acute renal failure, and issues related to pregnancy for women with renal transplants. It provides details on the incidence, risk factors, signs and symptoms, diagnosis, and management recommendations for each condition. The goal is to help physicians and obstetricians identify and treat renal disorders during pregnancy through careful monitoring, controlling risk factors like blood pressure and proteinuria, and joint management between specialists.
This document discusses various causes of jaundice that can occur during pregnancy. It begins with definitions of jaundice and normal liver physiology during pregnancy. It then discusses changes in liver function tests during pregnancy and the effects of maternal hyperbilirubinemia on the fetus. The main causes of jaundice unique to pregnancy are identified as intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, HELLP syndrome, and severe hyperemesis gravidarum. Viral hepatitis, gallstones, autoimmune disorders and drugs are identified as causes that can coincide with pregnancy. Details are provided on diagnosis and management of specific conditions like obstetric cholestasis, acute fatty liver of pregnancy, HEL
This document discusses the pharmacological management of preeclampsia with magnesium sulfate. It begins by outlining conditions treated with magnesium sulfate in obstetrics, including preterm labor, hypertensive disorders of pregnancy, and seizure prophylaxis. It then describes the pathophysiology of preeclampsia, mechanism of action of magnesium sulfate as an anticonvulsant and antihypertensive, potential interactions, adverse reactions, side effects, pharmacokinetics, and issues regarding drug binding. It concludes with improving communication around magnesium sulfate treatment and the application of related knowledge to clinical practice and nursing education.
This document discusses hypertensive disorders in pregnancy. It begins by noting that hypertensive disorders complicate about 10% of pregnancies and are a major cause of maternal and infant morbidity and mortality. The document then defines various types of hypertensive disorders like gestational hypertension, preeclampsia, eclampsia, and chronic hypertension. It discusses risk factors, pathogenesis, clinical features, maternal and fetal effects, diagnostic criteria and differential diagnosis of these conditions. The multi-organ pathophysiology and maternal syndrome are explained through placental hypoxia and endothelial dysfunction.
This document discusses cardiac disease in pregnancy. It notes that cardiac disease affects 1-2% of pregnancies and is a leading cause of maternal mortality. Rheumatic heart disease is the most common in many countries. Physiological changes in pregnancy like increased cardiac output place extra burden on the heart. Close monitoring and management of cardiac patients is needed before, during and after pregnancy to optimize outcomes for both mother and baby. A multidisciplinary team approach is important for treating women with heart disease through pregnancy.
This document discusses cardiac disease in pregnancy. It notes the physiological changes of increased cardiac output during pregnancy and describes common cardiac conditions like rheumatic heart disease and congenital heart defects. It provides details on managing specific conditions like mitral stenosis. Guidelines are presented for monitoring high-risk patients and minimizing cardiac stress during labor and delivery. The importance of a multidisciplinary approach between obstetricians and cardiologists is emphasized.
1) The document discusses classifications of hypertension in pregnancy and definitions of preeclampsia. Preeclampsia is defined as hypertension and proteinuria or signs of multi-organ involvement without proteinuria.
2) Antihypertensive medications are prescribed during pregnancy to prevent maternal complications of severe hypertension like cardiovascular and cerebrovascular events, not to cure preeclampsia.
3) Common antihypertensives discussed for use in pregnancy include methyldopa, hydralazine, labetalol, and nifedipine. Their mechanisms of action, dosages, and potential side effects are reviewed.
Hypertensive disorders are a leading cause of maternal and neonatal morbidity and mortality worldwide. Preeclampsia is characterized by new onset hypertension and proteinuria after 20 weeks of gestation and can progress to eclampsia with seizures. It is diagnosed when blood pressure is ≥140/90 mmHg on two occasions at least 4 hours apart accompanied by ≥300mg protein in 24 hour urine or a urine protein creatinine ratio of >0.3. Treatment involves blood pressure control with medications like labetalol, nifedipine and magnesium sulfate to prevent seizures. Delivery is usually required to resolve preeclampsia though timing depends on gestational age and maternal/fetal stability. Close monitoring of mother and
This document summarizes information about post-term pregnancy and induction of labor. It defines post-term pregnancy as beyond 42 weeks gestation, which increases risks of complications. Induction of labor is commonly recommended between 41-42 weeks to reduce risks. Common methods of induction include amniotomy, prostaglandins like misoprostol, and oxytocin infusion. Risks of induction include greater pain, uterine hyperstimulation, and potential need for C-section if induction fails. Accurate dating and fetal surveillance are important aspects of managing post-term pregnancies.
AKI in pregnancy can occur early, late, or post-pregnancy due to various causes. The most common cause is preeclampsia. HELLP syndrome, a severe form of preeclampsia, can cause AKI in 3-15% of cases. TTP and HUS may also precipitate AKI. Late pregnancy complications like AFLP, abruptio placenta, and amniotic fluid embolism can result in cortical necrosis and AKI. Prompt delivery is usually indicated for severe preeclampsia and AFLP. Management involves supportive care, dialysis, and addressing the underlying etiology. Outcomes depend on the severity and etiology of AKI, with cortical necrosis carrying the
This document discusses renal disease and pregnancy. It begins by outlining the normal physiological changes that occur in the kidney during pregnancy, including increased renal plasma flow, GFR, and dilatation of the collecting system. It then covers pregnancy-induced hypertension, including gestational hypertension, chronic hypertension, preeclampsia, and chronic hypertension with superimposed preeclampsia. The document also discusses acute kidney injury in pregnancy and chronic kidney disease and pregnancy. It provides details on diagnosis and management of various conditions.
Gestational diabetes mellitus (GDM) is a type of diabetes that develops during pregnancy. Rates of GDM are estimated to be 10-14.3% in India, higher than Western countries. Women with GDM and their offspring have an increased risk of developing type 2 diabetes later in life. Treatment for GDM involves medical nutrition therapy, physical activity, blood sugar monitoring, and potentially metformin or insulin therapy if blood sugar levels remain high. Proper management of GDM can help prevent complications for both mother and baby during pregnancy and reduce long-term health risks.
acute kidney injury during pregnancy, challenges in diagnosis and treatmentMarwa Elkaref
This document discusses acute kidney injury (AKI) during pregnancy. It begins by explaining the physiological changes in pregnancy that make diagnosing AKI difficult. It then discusses the causes and classifications of AKI during pregnancy. Some key causes mentioned include preeclampsia, HELLP syndrome, and septic abortion. The document outlines supportive management of renal function as well as treating the underlying disease. It notes that dialysis may be needed if other procedures are insufficient.
Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation. It can progress to eclampsia, which is characterized by new onset seizures. Risk factors include primigravidity, obesity, chronic hypertension, and diabetes. Symptoms may include headaches, visual disturbances, and epigastric pain. Diagnosis is based on blood pressure readings and urine protein levels. Delivery is the only cure, but magnesium sulfate can prevent seizures. Management involves monitoring vitals, administering antihypertensives cautiously, and delivering when condition warrants to minimize risks to mother and baby from preeclampsia.
Renal changes during pregnancy include:
1. Structural changes such as increased kidney size and volume due to vascular and interstitial fluid changes.
2. Systemic changes including resetting of osmoregulation and volume regulation set points to accommodate increased plasma volume. Hormonal changes like increased progesterone, relaxin, and erythropoietin also impact renal function.
3. Renal hemodynamic changes with glomerular filtration rate increasing up to 50% in the first trimester due to reduced oncotic pressure and increased ultrafiltration capacity, remaining elevated through pregnancy.
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
The document discusses the effects of pregnancy on thyroid physiology and function. It notes that thyroid stimulating hormone (TSH) levels are initially suppressed in the first trimester due to increased human chorionic gonadotropin (hCG) but become a reliable indicator again later in pregnancy. It provides references ranges for TSH, free T4, and total T4 in pregnancy and discusses screening and treatment of hypothyroidism. Maternal hypothyroidism can impact both maternal and fetal health outcomes.
This document discusses hypertensive disorders in pregnancy. It defines various types of hypertensive disorders including pregnancy-induced hypertension, pre-eclampsia, eclampsia, and chronic hypertension. It provides details on the pathophysiology, risk factors, clinical features, investigations, management, and complications of pre-eclampsia and eclampsia. Common antihypertensive drugs used for treatment are also mentioned.
Hormonal changes during pregnancy allow for increased blood flow to the kidneys and altered autoregulation such that glomerular filtration rate (GFR) increases significantly through reductions in net glomerular oncotic pressure and increased renal size.
1. Renal disorders are common in pregnancy and can include urinary tract infections, nephrolithiasis, and acute or chronic renal failure.
2. Physiologic changes in pregnancy include increased renal plasma flow and glomerular filtration rate to accommodate the needs of the growing fetus.
3. Urinary tract infections are frequent in pregnancy and can lead to asymptomatic bacteriuria or acute pyelonephritis if not treated.
4. Acute renal failure in pregnancy is usually prerenal from causes like hemorrhage, preeclampsia, or sepsis. It requires fluid resuscitation and treatment of the underlying condition.
Here are a few key things we can do:
1. Provide thorough preconception counseling to assess risk and optimize medical condition before pregnancy if possible.
2. Ensure careful multidisciplinary antenatal care involving cardiologists, obstetricians, anesthesiologists to monitor for complications.
3. Plan delivery carefully considering hemodynamic changes, with options for early delivery or C-section if needed.
4. Be vigilant for dangerous periods like labor/delivery when changes in volume and pressure occur abruptly. Have low threshold for ICU admission.
5. Educate patients and families on warning signs and ensure close postpartum follow up as this is a high risk period.
6.
Renal disorders are common in pregnancy and can affect both mother and baby if not properly managed. The document discusses several types of renal disorders that may occur, including urinary tract infections, chronic kidney disease, acute renal failure, and issues related to pregnancy for women with renal transplants. It provides details on the incidence, risk factors, signs and symptoms, diagnosis, and management recommendations for each condition. The goal is to help physicians and obstetricians identify and treat renal disorders during pregnancy through careful monitoring, controlling risk factors like blood pressure and proteinuria, and joint management between specialists.
This document discusses various causes of jaundice that can occur during pregnancy. It begins with definitions of jaundice and normal liver physiology during pregnancy. It then discusses changes in liver function tests during pregnancy and the effects of maternal hyperbilirubinemia on the fetus. The main causes of jaundice unique to pregnancy are identified as intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, HELLP syndrome, and severe hyperemesis gravidarum. Viral hepatitis, gallstones, autoimmune disorders and drugs are identified as causes that can coincide with pregnancy. Details are provided on diagnosis and management of specific conditions like obstetric cholestasis, acute fatty liver of pregnancy, HEL
This document discusses the pharmacological management of preeclampsia with magnesium sulfate. It begins by outlining conditions treated with magnesium sulfate in obstetrics, including preterm labor, hypertensive disorders of pregnancy, and seizure prophylaxis. It then describes the pathophysiology of preeclampsia, mechanism of action of magnesium sulfate as an anticonvulsant and antihypertensive, potential interactions, adverse reactions, side effects, pharmacokinetics, and issues regarding drug binding. It concludes with improving communication around magnesium sulfate treatment and the application of related knowledge to clinical practice and nursing education.
This document discusses hypertensive disorders in pregnancy. It begins by noting that hypertensive disorders complicate about 10% of pregnancies and are a major cause of maternal and infant morbidity and mortality. The document then defines various types of hypertensive disorders like gestational hypertension, preeclampsia, eclampsia, and chronic hypertension. It discusses risk factors, pathogenesis, clinical features, maternal and fetal effects, diagnostic criteria and differential diagnosis of these conditions. The multi-organ pathophysiology and maternal syndrome are explained through placental hypoxia and endothelial dysfunction.
This document discusses cardiac disease in pregnancy. It notes that cardiac disease affects 1-2% of pregnancies and is a leading cause of maternal mortality. Rheumatic heart disease is the most common in many countries. Physiological changes in pregnancy like increased cardiac output place extra burden on the heart. Close monitoring and management of cardiac patients is needed before, during and after pregnancy to optimize outcomes for both mother and baby. A multidisciplinary team approach is important for treating women with heart disease through pregnancy.
This document discusses cardiac disease in pregnancy. It notes the physiological changes of increased cardiac output during pregnancy and describes common cardiac conditions like rheumatic heart disease and congenital heart defects. It provides details on managing specific conditions like mitral stenosis. Guidelines are presented for monitoring high-risk patients and minimizing cardiac stress during labor and delivery. The importance of a multidisciplinary approach between obstetricians and cardiologists is emphasized.
1) The document discusses classifications of hypertension in pregnancy and definitions of preeclampsia. Preeclampsia is defined as hypertension and proteinuria or signs of multi-organ involvement without proteinuria.
2) Antihypertensive medications are prescribed during pregnancy to prevent maternal complications of severe hypertension like cardiovascular and cerebrovascular events, not to cure preeclampsia.
3) Common antihypertensives discussed for use in pregnancy include methyldopa, hydralazine, labetalol, and nifedipine. Their mechanisms of action, dosages, and potential side effects are reviewed.
Hypertensive disorders are a leading cause of maternal and neonatal morbidity and mortality worldwide. Preeclampsia is characterized by new onset hypertension and proteinuria after 20 weeks of gestation and can progress to eclampsia with seizures. It is diagnosed when blood pressure is ≥140/90 mmHg on two occasions at least 4 hours apart accompanied by ≥300mg protein in 24 hour urine or a urine protein creatinine ratio of >0.3. Treatment involves blood pressure control with medications like labetalol, nifedipine and magnesium sulfate to prevent seizures. Delivery is usually required to resolve preeclampsia though timing depends on gestational age and maternal/fetal stability. Close monitoring of mother and
This document summarizes information about post-term pregnancy and induction of labor. It defines post-term pregnancy as beyond 42 weeks gestation, which increases risks of complications. Induction of labor is commonly recommended between 41-42 weeks to reduce risks. Common methods of induction include amniotomy, prostaglandins like misoprostol, and oxytocin infusion. Risks of induction include greater pain, uterine hyperstimulation, and potential need for C-section if induction fails. Accurate dating and fetal surveillance are important aspects of managing post-term pregnancies.
AKI in pregnancy can occur early, late, or post-pregnancy due to various causes. The most common cause is preeclampsia. HELLP syndrome, a severe form of preeclampsia, can cause AKI in 3-15% of cases. TTP and HUS may also precipitate AKI. Late pregnancy complications like AFLP, abruptio placenta, and amniotic fluid embolism can result in cortical necrosis and AKI. Prompt delivery is usually indicated for severe preeclampsia and AFLP. Management involves supportive care, dialysis, and addressing the underlying etiology. Outcomes depend on the severity and etiology of AKI, with cortical necrosis carrying the
This document discusses renal disease and pregnancy. It begins by outlining the normal physiological changes that occur in the kidney during pregnancy, including increased renal plasma flow, GFR, and dilatation of the collecting system. It then covers pregnancy-induced hypertension, including gestational hypertension, chronic hypertension, preeclampsia, and chronic hypertension with superimposed preeclampsia. The document also discusses acute kidney injury in pregnancy and chronic kidney disease and pregnancy. It provides details on diagnosis and management of various conditions.
Gestational diabetes mellitus (GDM) is a type of diabetes that develops during pregnancy. Rates of GDM are estimated to be 10-14.3% in India, higher than Western countries. Women with GDM and their offspring have an increased risk of developing type 2 diabetes later in life. Treatment for GDM involves medical nutrition therapy, physical activity, blood sugar monitoring, and potentially metformin or insulin therapy if blood sugar levels remain high. Proper management of GDM can help prevent complications for both mother and baby during pregnancy and reduce long-term health risks.
acute kidney injury during pregnancy, challenges in diagnosis and treatmentMarwa Elkaref
This document discusses acute kidney injury (AKI) during pregnancy. It begins by explaining the physiological changes in pregnancy that make diagnosing AKI difficult. It then discusses the causes and classifications of AKI during pregnancy. Some key causes mentioned include preeclampsia, HELLP syndrome, and septic abortion. The document outlines supportive management of renal function as well as treating the underlying disease. It notes that dialysis may be needed if other procedures are insufficient.
Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation. It can progress to eclampsia, which is characterized by new onset seizures. Risk factors include primigravidity, obesity, chronic hypertension, and diabetes. Symptoms may include headaches, visual disturbances, and epigastric pain. Diagnosis is based on blood pressure readings and urine protein levels. Delivery is the only cure, but magnesium sulfate can prevent seizures. Management involves monitoring vitals, administering antihypertensives cautiously, and delivering when condition warrants to minimize risks to mother and baby from preeclampsia.
This document defines preeclampsia and eclampsia, describes their mechanisms and risk factors, lists symptoms, diagnostic criteria and complications. It outlines investigations done and management which includes delivery as the only cure, antihypertensive treatment, seizure prophylaxis with magnesium sulfate, and fluid management. Preeclampsia is defined as new hypertension and proteinuria after 20 weeks gestation while eclampsia involves new onset seizures in the context of preeclampsia. Risk factors include primigravidas, family history, age over 35, and chronic conditions. Management aims to stabilize the mother until delivery can be safely performed to resolve the condition.
Renal parenchymal disease in Obstretic patients.pptxgauthampatel
This document discusses renal parenchymal disease and acute renal failure during pregnancy. It begins by outlining the main types of renal parenchymal disease - glomerulopathies and tubulointerstitial diseases. It then discusses the various causes, presentations, diagnoses, and management considerations for acute renal failure during pregnancy, including prerenal, intrarenal, and postrenal causes like preeclampsia. Key complications for both the mother and fetus are noted. The document provides detailed information on evaluating and treating patients with renal disease or failure during pregnancy.
nausea and vomiting in pregnancy is very common. it may be a manifestation of some medical - surgical - gynecological complications. hyperemesis gravidarum is a severe type of vomiting in pregnancy which has got deleterious effects on the health of the mother. it is a very important topic and it is also a topic in obstetrics. we should encourage and help young mothers to identify the symptoms. please read it and get knowledge about nausea and vomiting in pregnancy. stay tuned.
Neonatal emergencies require rapid assessment and treatment to identify and manage potential respiratory, circulatory or neurological failure. The key is early recognition and treatment of reversible life-threatening conditions. This document outlines signs, causes, investigations and management approaches for common neonatal emergencies involving the respiratory (e.g. respiratory distress syndrome), cardiovascular (e.g. congenital heart defects), neurological (e.g. seizures), hematologic (e.g. anemia), gastrointestinal (e.g. necrotizing enterocolitis) and metabolic (e.g. hypoglycemia) systems. Initial stabilization is followed by identification of specific conditions and initiation of targeted therapies.
Liver and kidney diseases can complicate pregnancy. Unique liver diseases include intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), and HELLP syndrome. ICP causes pruritus and jaundice. AFLP results in fatty infiltration of hepatocytes. Kidney diseases increase risks of preeclampsia, preterm birth, and infection. Acute pyelonephritis is common. Chronic kidney disease poses high risks. Pregnancy while receiving dialysis or after transplant requires monitoring due to hypertension and infection risks.
Hyperemesis Gravidarum is a severe form of nausea and vomiting during pregnancy that can lead to dehydration, metabolic disturbances, and weight loss of over 5%. It affects approximately 0.3-3% of pregnancies. The cause is multifactorial but is linked to high levels of hCG and other hormones. Clinically it presents with persistent vomiting and signs of dehydration. Treatment involves intravenous rehydration, antiemetics, thiamine supplementation, and monitoring for complications like Wernicke's encephalopathy. With treatment, the symptoms typically resolve by 12-14 weeks of gestation though may recur in future pregnancies.
This document discusses the approach to a case of neonatal liver failure. It begins by describing the case presentation and initial workup. Key points include that metabolic diseases are a common cause of neonatal liver failure. The document then discusses priorities in management, which include stabilizing life-threatening issues and pursuing diagnostic testing. Common causes like galactosemia, tyrosinemia, and HSV hepatitis are discussed. The case is ultimately diagnosed as mitochondrial DNA depletion syndrome based on genetic testing. Important lessons are around promptly considering and evaluating for metabolic etiologies in neonatal liver failure cases.
This document discusses the approach to a case of neonatal liver failure. It begins by describing the case presentation and initial workup. Key points include that metabolic diseases are a common cause of neonatal liver failure. The document then discusses priorities in management, which include stabilizing life-threatening issues and starting investigations. Common causes like galactosemia, tyrosinemia, and HSV hepatitis are discussed. Newer concepts in management like N-acetylcysteine are also covered. Finally, the case is summarized as mitochondrial DNA depletion syndrome caused by a novel mutation in the DGUOK gene.
The document summarizes various liver conditions that can cause jaundice in pregnancy. It discusses physiological changes in the liver during pregnancy and various causes of jaundice related and unrelated to pregnancy. These include viral hepatitis, intrahepatic cholestasis of pregnancy (ICP), preeclampsia, HELLP syndrome, and acute fatty liver of pregnancy (AFLP). It provides details on pathogenesis, clinical presentation, management and prognosis for these conditions. Pregnancy-related liver disorders can affect both mother and fetus, so prompt diagnosis and treatment are important.
Preeclampsia is a multi-system disorder characterized by new onset hypertension and proteinuria after 20 weeks of gestation. It is caused by placental and maternal vascular dysfunction and resolves after delivery. Preeclampsia affects nearly 10% of pregnancies and can lead to significant maternal and fetal morbidity and mortality. It is classified as mild or severe depending on severity of symptoms. Treatment involves monitoring for signs of worsening and delivering the baby if the condition progresses or fetal maturity is sufficient. Magnesium sulfate is used to prevent seizures in severe preeclampsia.
This document discusses fluid compartments in the human body and how pregnancy affects fluid dynamics. It describes the physiology of fluid distribution between intracellular and extracellular spaces and how volumes change during pregnancy. It also outlines different types of fluid resuscitation therapies, including crystalloid and colloid solutions, and discusses their characteristics and appropriate uses. Finally, it addresses blood components, indications for blood transfusion in obstetrics, and ways to reduce transfusion needs.
This document discusses hypertensive disorders associated with pregnancy. It defines gestational hypertension as developing after 20 weeks of gestation without proteinuria and resolving postpartum. Preeclampsia is defined as developing after 20 weeks with elevated blood pressure and proteinuria. It can cause HELLP syndrome or eclampsia. Risk factors for preeclampsia include primigravidity, obesity, chronic hypertension, and African American race. Pathophysiology involves endothelial dysfunction and increased sensitivity to vasoconstrictors. Management involves seizure prophylaxis with magnesium sulfate and antihypertensive therapy like hydralazine, labetalol, or nifedipine to control maternal blood pressure until delivery.
Liver disease in pregnancy can have severe maternal and fetal effects. Unique conditions include hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, HELLP syndrome, and acute fatty liver of pregnancy. Physiological changes occur in hepatic parameters during pregnancy. Conditions like viral hepatitis and cirrhosis may impact an existing pregnancy. Accurate diagnosis and management of liver conditions is important to optimize outcomes.
Pregnancy in hemodialysis dr salwa elwasefFarragBahbah
This document discusses pregnancy in women undergoing hemodialysis. It notes that while rare, pregnancy is possible but comes with increased risks of complications for both the mother and fetus. These can include worsening hypertension, preterm labor, growth restriction, and others. The document provides guidance on managing these risks through frequent hemodialysis, strict fluid control, medication adjustments, nutritional supplementation, and multidisciplinary care. The goal is to allow for safe continuation of pregnancy while minimizing health impacts on the mother and optimizing fetal development.
This document discusses diabetic ketoacidosis (DKA) during pregnancy. It defines DKA and outlines its epidemiology, pathophysiology, diagnosis, differential diagnosis, prevention, treatment, and complications. DKA is a medical emergency that occurs more commonly in pregnant women with poorly controlled diabetes. During pregnancy, DKA can develop more rapidly due to insulin resistance. Treatment involves rehydration, insulin therapy, electrolyte correction, and monitoring of both mother and fetus until metabolic stability is achieved. Fetal monitoring is important given risks of distress, death, or developmental impacts from maternal acidosis and electrolyte disturbances.
1. Myxedema coma is a life-threatening complication of severe untreated hypothyroidism, often precipitated by an acute illness. It involves altered mental status and multiple organ dysfunction.
2. Clinical features include symptoms of hypothyroidism along with hypothermia, hypotension, hypoventilation, coma and signs of precipitating illnesses. Investigations show features of hypothyroidism.
3. Treatment involves intensive care support including ventilatory support, cardiac monitoring and gradual rewarming. Thyroid hormone replacement is given cautiously along with treating any underlying illnesses.
The document discusses HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome, a rare complication of preeclampsia. It defines HELLP as hepatic endothelial disruption followed by platelet activation and consumption, resulting in ischemia and hepatocyte death. The summary discusses risk factors, symptoms, diagnosis, complications including subcapsular liver hematoma, and management including delivery considerations, postpartum care, and potential for rapid deterioration requiring intensive monitoring. It also reviews a research study on use of the Mississippi classification system for HELLP.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
3. Acute Kidney Injury (AKI)
• AKI is known as prompt decrease in renal function
over a period of several hours to days sufficient
enough to result in retention of nitrogenous waste
products in body.
• The physiological changes in pregnancy make
diagnosis of AKI difficult.
It is also known as acute renal failure (ARF)
4. AKI Contd…
ARI is suspected in the following conditions:
• Oliguria: (urine output of <30 ml/hour or <400 ml/24
hrs
• Anuria
• Deteriorating renal function as demonstrated by rising
serum creatinine
(Creatinine level ≥1 mg/dl of rapid rise (in 48 hrs) of
0.5 mg/dl above baseline
5. Incidence
• More common problem in the developing nation but
lesser incidence due to the improvement in antenatal
care and the reduction of septic abortion due to its
legalization
• Socioeconomic factors contributing to PRAKI in the
underdeveloped countries are mainly due to poverty,
poor obstetrics care, lack of proper healthcare
facilities and awareness of the condition, delayed
referral process, multiparity, and the increasing
population number.
6. Incidence Contd..
• The rate of PRAKI in Canada increased from 1.6 per
10 000 deliveries in 2003 to 2.3 per 10 000 deliveries in
2007.
• United States : rate increased from 2.3 to 4.5 per
10 000 deliveries over a 10-year period between 1998
and 2008
• The reason for the growing rate of PRAKI, that is
possibly not actual incidence, might be due to the
increasing sensitivity of AKI diagnosis with close
obstetric observation, particularly in high risk
pregnancy. Moreover, the incidence of dialysis required
PRAKI also declined.
7. Classification of AKI (KDIGO)
(The Kidney Diseases: Improving Global
Outcomes)
Stage Serum creatinine concentration Urine output
criteria
1 SCr 1.5-1.9 times baseline OR
≥26.5 ummol/L (0.3 mg/dL)
increase
<0.5 ml/kg/h for 6-
12 hrs
2 SCr 2-2.9 times baseline <0.5 ml/kg/h for 6-
12 hrs
3 SCr 3 times baseline OR Initiation
of renal replacement therapy OR In
pts <18 yrs, decrease in GFR to
<35ml/min/1.73m2
Anuria for ≥12 hrs
9. Contd…
• Unfortunately, the mentioned definition of AKI is not
valid for pregnant women due to the physiological
changes during pregnancy
10.
11.
12. Causes
Early in pregnancy
Prerenal cause
• Hyperemesis
gravidiaum
• Hemorrhage
-Abortion
-Ruptured ectopic
pregnancy
• Sepsis
-Septic abortion
Pregnancy being
associated with
heightened
inflammation, changes
to vascular
endothelium, and a
prothrombic state, is
more likely to favor the
development of ATN
13. Causes Contd…
Hperemesis gravidarum
• Present in first trimester of pregnancy with acute
renal failure associated with a hypovolemic,
metaolic allkalosis.
Abortion
• Is an infected abortion complicated by fever.
Endometritis and parametritis and it remains one of
the most serious threats to woman's health.
14. Causes Contd…
Third trimester and postpartum period
Prerenal causes
– APH (placenta abruption)
– PPH
Intrarenal causes
– Severe pre-eclampsia
– HELLP Syndrome
– Acute fatty liver of pregnancy
– Thrombotic microangiopathies
15. Causes Contd…
Preeclampsia : major cause of renal dysfunction during
pregnancy.
• It is accompanied by a specific renal lesion known as
glomerular endotheliosis, in which the glomruli enlarge
and become ischemic.
• Characterized by general vasoconstriction and
hemoconcentration with a reduced intravascular volume.
16. Causes Contd…
HELLP
• Is a syndrome characterized by hemolysis, elevated
liver enzymes and low platelet count/
• 5-10% of women with pre-eclampsia develop
HELLP
• AKF occur in up to 40% of women with HELLP
syndrome
• ARF may be a result of direct renal injury or as a
consequences of abruption.
17. Causes Contd…
Acute Fatty Liver of Pregnancy
• It is defined as microvesicular fatty infiltration of
hepatocytes during second half of pregnancy, and it
remains a common cause of liver failure in pregnancy
• It is associate with ARF in up to 60% of cases.
• There is decreased renal perfusion or acute tubular
necrosis (ATN).
18. Causes Contd…
Thrombotic Microangiopathies
• Combination of thrombocytopenia and
microangiopathic anaemia.
• Rare and affect 1 per 25000 pregnancies
• Presence of fibrin and/ or platelet thrombi in the
microcirculation of multiple organs. (most affected
organ: brain or kidney)
• Clinical entities described:
Thrombocytopenic purpura (TTP)
Hemolytic uremic syndrome (HUS)
19. Causes Contd…
• TTP: is characterized by fever, thrombocytopenia,
micronagiopathic hemolytic anaemia, mild renal
failure (creatinine <1.4mg/dl) and neurologic
symptoms (disorientation, ataxia, headache, focal
changes, seizures or aphasia)
• HUS: occasionally develops as a complication of
preeclampsia. Featurs of HUS are similar, but
neurological involvement is rare while renal
involvement is profound (creatinine>2.3mg/dl).
20. Others Causes
Nephrotoxic Drugs
• NSAIDs when given to the mother peripatrum,
reduce renal blood flow and can cause acute renal
impairment to both mother and fetus.
• Women with reduced intravascular volume,
especially if they have pre-existing renal
impairment.
• Indomethacin may also precipitate hyperkalemia.
21. Others Contd…
Post-operative Oliguria
• It is usually secondary to hypovolemia from
hemorrhage , although renal function may also be
depressed by general anaesthesia.
25. AKI treatment in Pregnancy
• There are 3 aspects to consider in the management of
AKI related to pregnancy
1. Renal function supportive measures
2. Treatment of underlying disease
3. Dialysis
26. Treatment Contd…
1.Renal function supportive measures
• Etiological treatment, suspension of nephrotoxic
drugs or treatment of an infectious disease should be
started as soon as possible.
• Administration of IV fluids to restore and maintain
renal perfusion also prevents hypovolemia and
ensures an adequate uteroplacental perfusion and fetal
well-being.
27. Treatment Contd…
• Pharmacologic therapy of AKI and its known
complications: hypertension, hyperkalemia, metabolic
acidosis and anemia.
• Antihypertensive drugs: first-line treatment options in
pregnant women are methyldopa and labetalol
• Hyperkalemia : should be promptly corrected using
glucose/insulin or potassium-binding resins such as
polystyrene sulfonate.
• Anemia: blood transfusion is recommended in acute
therapy. The erythropoiesis-stimulating agents are safe in
pregnancy, but higher doses are usually required to obtain
the desired therapeutic effect.
28. Treatment Contd…
2. Treatment of the underlying disease
i. Unsafe abortion
Prevention of unwanted pregnancy and avoidance of septic
abortion are key to eliminate abortion associated AKI in early
pregnancy .
Fluid therapy: should start immediately and larger amounts
may be needed but must be done with careful monitoring to
ovoid overload.
29. Treatment Contd…
• Antimicrobial therapy: IV antibiotics should be
started as early as possible always within first hour or
recognizing sepsis
• Blood product administration: if coagulopathy
develops
30. Treatment Contd…
ii. Hyperemesis
• Fluid and electrolyte replacement.
• Avoid dextrose containing fluids which may precipitate
wernicke’s encepahopathy.
• Withhold non—essential drug associated with nausea and
vomiting as iron supplementation
• A combination of antiemetic medications may be required
31. Treatment Contd…
Preeclampsia /HELLP
• Delivery for oliguria or a rise in serum creatinine from normal
to >1.3mg/dl
• In case of hypovolumia, severe creatinine 1.0-1.36 mg/dl, and
no clinical signs of pulmonary edema- fluid challenges.
• CVP monitoring: in case of serum creatinine >1.36mg/dl,
refractory HTN, or multisystem organ failure
• IV hydralazine or low dose dopamine infusion (2.5
ug/kg/mim) if necessary.
• Furosemide infusion (5 mg/hr) and fluid restriction if
necessary.
• Continue invasive central hemodynamic monitoring until the
diuretic phase in postpartum.
• Corticosteroid : used to accelerate fetal lung maturity followed
by delivery after 24 hrs.
32. Treatment Contd…
AFLP
• It is important to confirm diagnosis because women with AFLP
can rapidly develop liver failure and encephalopathy.
• Admit to ICU. Invasive hemodynamic monitoring may be
necessary.
• Maternal stabilization condition glycemic control with glucose
administration and coagulopathy correction with fresh frozen
plasma, BT or cryoprecipatitate is essential.
33. Treatment Contd…
AFLP
• Hepatic encephaopathy is treated with low protein diet and
oral lactulose.
• Delivery should be induced immediately to avoid progression
to liver failure.
• Monitor clotting, hypoglycemia and fluid balance before and
after delivery.
• Temporary dialysis occasionally.
34. Treatment Contd…
• TTP and HUS sharing overlapping features and may be difficult to
differentiate from each others.
TTP
• Differentiate from pre-eclampsia
• Plasma infusion may be first-line approach in case with less severe
thrombocytopenia.
• Plasmapheresis is preferable in cases with severe hematologic
manifestations
• Anti platelet therapy (aspirin, dipyridamole) in conjunction with plasma
exchange.
35. Treatment Contd…
• Immunosuppressive therapy (prednisone,
cyclophosphamide, vincristine or rituxmab) or
splenectomy, or both, for non responders to plasma
exchange.
• Consider delivery at 34 weeks.
36. Treatment Contd…
HUS
• Dialysis for most cases
• Red cell transfusion for severe anemia
• Plasma exchange and prednisone until 4 wks
postpartum
37. Treatment Contd…
2. Dialysis : if the previous procedures prove to be
insufficient , dialysis is the next step
Indication
• Electrolyte imbalance especially hyperkalemia
• Metabolic acidosis
• Volume overload
• Symptomatic uremia
-Pericarditis
-Neuropathy
-Mental status changes
38. Treatment Contd…
• Dialysis should be initiated when the serum creatinine level is
3.5-5.0 mg/dL or the glomerular filtration rate (GFR) is below
20 ml/min.
40. Introduction
• Chronic Kidney Disease (CKD) is an umbrella term that
describes irreversible kidney damage or a decrease in the
GFR for three or more months.
• Gradual and usually permanent loss of kidney function
occurs over time, usually months to years.
• CKD is associated with decreased quality of life,
increased health care expenditures, and premature death.
• Untreated CKD can result in ESRD and necessitate renal
replacement therapy.
41. Introduction Contd…
• CKD leads to:
disturbed excretion of end products of metabolism
disturbed elimination of electrolytes and water
disturbed secretion of hormones(eg. Erythropoietin, renin,
prostaglandins, active form of vitamin D)
42. Classification
• Mild renal insufficiency : serum creatinine of 1.3mg/dl
or less
• Moderate renal insufficiency :serum creatinine of 1.3 to
1.9 mg/dl
• Severe renal insufficiency: serum creatinine of 1.9mg/dl
or greater.
• Chronic renal insufficiency is characterized by oliguria
or anuria requiring dialysis
43. Staging of CKD (KDIGO)
GFR categoties in CKD
GFR category GFR (ml/min/1.73
m2)
Terms
G1 >90 Normal or high
G2 60-89 Mildly decreased
G3a 45-59 Mildly to
moderately
decreased
G3b 30-44 Moderately to
severely decreased
G4 15-29 Severely decreased
G5 <15 Kidney failure
44.
45. Staging of CKD according to National Kidney
Foundation
• Stage 1: Kidney damage with normal kidney function (estimated
GFR ≥90 mL/min per 1.73 m2) and persistent (≥3 months)
proteinuria.
• Stage 2: Kidney damage with mild loss of kidney function
(estimated GFR 60-89 mL/min per 1.73 m2) and persistent (≥3
months) proteinuria.
• Stage 3: Mild-to-severe loss of kidney function (estimated GFR 30-
59 mL/min per 1.73 m2).
• Stage 4: Severe loss of kidney function (estimated GFR 15-29
mL/min per 1.73 m2).
• Stage 5: Kidney failure requiring dialysis or transplant for survival.
Also known as ESRD (estimated GFR <15 mL/min per 1.73 m2).
46. Epidemiology
• Fertility is substantially decreased in women with GFRs less
than 50%
• Eighty five percent of women with renal disease will have a
surviving infant
• Worsening renal function is directly correlated with pre
pregnancy creatinine.
• One- third of women with pre-existing moderate to severe renal
insufficiency will develop end stage renal disease within 1 year
of delivery
• Uncontrolled hypertension is the single most important indicator
of poor pregnancy outcome
• Women with renal disease requiring dialysis, 2% of hemodialyis
will conceive over a 4 year period versus 1% women treated
with peritoneal dialysis
47. Etiology
• Most common cause are
Diabetes mellitus-33%
Hypertension- 24%
Glumerulonephritis -17%
Ploycystic kidney disease – 5%
• The etiologies that have been associated with worsening of
renal disease in pregnancy are:
Membrano proliferative glumerulonephritis
Reflux nephropathy
Immunoglobulin nephropathy
Focal sclerosis
48. Pathophysiology
• Impairment of acid-base regulation predispose the fetus to
acidemia
• Inadequate blood pressure control is associated with a dismal
obstetric prognosis
• Hypertension secondary to renal disease places the fetus at risk
due to:
Uteroplacental insufficiency
Decreased perfusion
Decreased oxygen availability
49.
50. Clinical Features
• Urinary- Polyuria, Oliguria, Anuria
• Cardiovascular – Hypertension, pitting odema, engorged
neck veins, Pericardial effusion, uremic pericarditis,
• Integumentary; Dry, pale skin, severe pruritus, ecchymosis,
thin brittle nails, uremic frost ( rare).
• Pulmonary; Tenacious sputum , depressed cough reflex,
shortness of breath, kussmaul’s respiration, pleuritic pain,
uremic pluritis.
• Neurological : Weakness and fatigue, confusion, Inability to
concentrate, Disorientation, seizures and coma.
51. Clinical Features Contd…
• Musculoskeletal: Muscle cramp, loss of muscle strength
• Gastrointestinal: metallic taste, anorexia, nausea and
vomiting, constipation, bleeding from GI, weight loss, uremic
fetor ( urinous odor of breath).
• Hematological: Anemia, Bleeding tendency
• Reproductive: Infertility, decreased libido, amenorrhea in
female, sexual dysfunction.
• Psychological changes: Personality and behavioral changes,
withdrawal, depression
52. Evaluation
• Baseline 24 hrs urine collection for protein and creatinine
clearance should ne obtained and repeated monthly.
• Nephrotic – range proteinuria is most commonly due to
precclampsia in women with underlying renal disease.
• The appearance of worsening proteinuria is common but
does not necessarily portend worsening of renal function.
• Baseline serum creatinine with repeated assessment at
regular intervals.
53. Evaluation Contd…
• Baseline blood pressure with home monitoring
• Prenatal visit at least twice monthly.
• Targeted ultrasound at 18 to 20 weeks followed by monthly
sonogram to assess for fetal growth restriction.
• Antepartum fetal testing were starting at 32 weeks of gestation
or earlier if severe hypertension, preeclampsia or other
specific complication occurs.
54. Management
1. Pre pregnancy counseling
• Women should be counseled by a multidisciplinary
team as fertility, as well as pregnancy outcome,
depends on the degree of renal insufficiency.
A discussion about
– risks of pre-eclampsia,
– fetal growth restriction
– preterm delivery
– about the long-term risks to their own health
– risk of deterioration in renal function following
pregnancy.
55. Pre pregnancy counseling Contd..
• Single embryo transfer should be recommended to
women undergoing in vitro fertilization. This is the
ideal opportunity to establish baseline renal function
and achieve optimal control of hypertension.
• ACE inhibitors and angiotensin receptor blockers are
contraindicated in pregnancy. They do, however,
provide significant renal protection and hence the
current recommendation is to change over to safer
drugs after the woman becomes pregnant.
56. 2. Medical Management
• Hypertension: Beta blockers, calcium channel
blockers and hydralazine.
• Amaemia: ferrous sulfate, erythropoietin and /or
transfusion
57. 3. Obstetric management
• More frequent hospital visits, depending on the clinical
situation.
• Regular scans are recommended every 4 weeks from 28 weeks
of gestation onwards to check growth as well as liquor
volume.
• Consideration should be given to prophylactic low dose aspirin
for the prevention of pre-eclampsia.
• Blood pressure monitoring and adequate control are important.
58. 3. Obstetrical Management Contd…
• Preterm labour is common. The prompt treatment of
bacterial vaginal and urinary tract infections,
including asymptomatic bacteriuria, can be helpful
for prevention of preterm labour.
• Women with recurrent urinary tract infections should
be given antibiotic prophylaxis throughout pregnancy.
59. Obstetrical Management Contd…
In the absence of maternal or fetal deterioration,
• Delivery should be planned at or near term.
• Early delivery is usually necessary for
obstetric indications such as pre-eclampsia and fetal growth restriction
or
for rapidly deteriorating maternal renal function.
• Obstetric considerations should be the main determinant for
caesarean section.
• Women with nephrotic syndrome should receive prophylactic
heparin in pregnancy as well as for 6 weeks postpartum.
61. Outcome
Maternal outcome
• Pregnancy, when it occurs in women with CKD, is considered
high risk.
• Pregnancy is rare when serum creatinine rises beyond 3 mg/dl as
either these females have amenorrhea or have anovulatory cycles.
In case if pregnancy does occur in these women about a third will
progress to ESRD in 1 year post partumigh risk.
• Nephrotic proteinuria is common. There may be increase in
maternal mortality and increase in the incidence of cesarean
deliveries.
62. Outcome Contd…
Fetal outcome
• Spontaneous abortion and intrauterine growth retardation is
frequent.
• Full-term delivery is less common and stillbirth and low birth
weight are higher in women with CKD stages 3 and 4.
• Live birth rate varies with the stage of CKD and is 98% in
mild renal failure and 90% in those with moderate renal failure
while those with severe renal failure have 50% fetal loss.
(Sahay,2015).
63. Patient Education
Patient must be educated regarding
– The risk of pregnancy and worsening renal function or
resultant end stage renal disease within 1 year of delivery.
– Recommendation for termination if renal function and
blood pressure acutely worsen in the first trimester.
– The need for intensive monitoring throughout the
pregnancy to optimize maternal and fetal outcome.
64. References
Arun, J. (2017). AKI during pregnancy, pregnancy-related acute
kidney injury, acute renal failure in pregnancy. Retrieved from
www.clinicaladvisor.com › Decision Support in Medicine › Critical
Care Medicine.
Evansm A.T., & DeFranco,E. (2015). Manual of obstetris (2nd ed.).
India: Wolters kluwer.
Edmonds, K. (2012). Dewhurst’s textbook of obstetrics and
gynaecology (8th edition). London: Willey blackwell.
James., Steer., Weiner., Gonik., Croether., & Robson. (2012). High risk
pregnancy management option (4th ed.). India: Elsevier.
65. References Contd…
Kapoor , N.,Makanjuola , D., & hehata, S. (2008). Management of women
with chronic renal disease in pregnancy. Retrieved from
http://onlinetog.org.
• KDIGO (2012). KDIGO Clinical practice guideline for acute kidney injury.
Journal of the international society of nephrology, 2(1)
Krane, N. K. (2015). Renal Disease and Pregnancy. Retrieved from
emedicine.medscape.com/article/246123-overview.
Machado, S., Figueiredo, N., Borges, A., Pais, M.S., Freitas, L., Moura., &
Campos, M. (2012). Acute kidney injury in pregnancy: a clinical
challenges. 25 (1)). Doi: 10.5301/jn.5000013.
• Michael Hnat, M., & Sibai, B.M. (2008). Renal Disease and Pregnancy.
66. References Contd…
• The Global Library of Women's Medicine.
doi:10.3843/GLOWM.10157.
• Sahay, M. (2015). Pregnancy in chronic kidney disease. Indian
journal of nephrology. 25 (4). doi:10.4103/0971-4065.147768.
• Seshadri, L., & Arjun, G. (2016). Essentials of obstetrics (2nd
ed.). India: Wolters kluwer.
Editor's Notes
Membranoproliferative glomerulonephritis ("MPGN"), also known as mesangiocapillary glomerulonephritis, is a type ofglomerulonephritis caused by deposits in the kidney glomerular mesangium and basement membrane (GBM) thickening, activating complement and damaging the glomeruli.
IgA nephropathy, also known as Berger's disease, is akidney disease that occurs when IgA deposits build up in the kidneys, causing inflammation that damages kidney tissues.
Ecchymosis: a discoloration of the skin resulting from bleeding underneath, typically caused by bruising
Uremic frost is a colloquial description for crystallized urea deposits that can be found on the skin of those affected by chronic kidney disease.
Pleuritic chest pain is characterized by sudden and intense sharp, stabbing, or burning pain in the chest when inhaling and exhaling.
Kussmaul breathing is a deep and laboredbreathing pattern often associated with severe metabolic acidosis, particularly diabetic ketoacidosis (DKA) but also kidney failure